G2GBio Inc (456160)

Currency in KRW
40,950
-100(-0.24%)
Closed·
Advertisement
456160 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
40,75043,950
52 wk Range
22,400200,500
Key Statistics
Bid/Ask
40,950.00 / 41,000.00
Prev. Close
40,950
Open
43,350
Day's Range
40,750-43,950
52 wk Range
22,400-200,500
Volume
119.72K
Average Volume (3m)
184.19K
1-Year Change
3.671%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
456160 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Earnings

Latest Release
-
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

G2GBio (456160) Income Statement & Profits

Compare 456160 to Peers and Sector

Metrics to compare
456160
Peers
Sector
Relationship
P/E Ratio
0.0x−9.1x−0.3x
PEG Ratio
0.000.020.00
Price/Book
0.0x1.8x2.6x
Price / LTM Sales
0.0x7.0x3.1x
Upside (Analyst Target)
0.0%17.2%48.5%
Fair Value Upside
Unlock20.1%6.3%Unlock

G2GBIO Inc., a clinical-stage biotech company, provides pharmaceutical products. The company’s pipeline products include GB-5001, GB-5001A, and GB-5112 for the treatment of Alzheimer’s disease; GB-6002, an opioid drug that is used for post-operative pain treatment; GB-7001 for type-2 diabetes treatments; GB-5313 for the treatment of Osteoarthritis; GB-7101 and GB-7103 for the treatment of prostate cancer; GB-6201 and GB-6203 for androgenetic alopecia treatments; and GH-001 for the treatment of Hepatitis B. It also develops GB-2001 for animal castration; and GB-2006, an animal postoperative pain relief drug, which is in clinical trial stage. The company was founded in 2017 and is headquartered in Cheongju-si, South Korea.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
539.04K3.26%22.13B
Other Institutional Investors
2.00M12.10%82.19B
Public Companies & Retail Investors
14.00M84.64%574.87B
Total
16.55M100.00%679.19B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Atinum Growth Fund 20233.38%558,53722,927,944
Vanguard Capital Management, LLC3.04%503,00620,648,396

People Also Watch

12,650
010170
-0.39%
115,400
031980
+2.85%
21,250
397030
-19.20%
109,400
226950
+4.79%
459,500
307950
+5.27%

FAQ

What Is the G2GBio (KOSDAQ: 456160) Share Price Today?

The G2GBio stock price today is 40,950 KRW.

What Stock Exchange Does G2GBio (456160) Trade On?

G2GBio is listed and trades on the KOSDAQ.

What Is the Ticker (Stock Symbol) for G2GBio?

The stock symbol (also called a 'ticker') for G2GBio is "456160."

What Is the Current G2GBio Market Capitalisation?

As of today, G2GBio (KOSDAQ: 456160) market cap is 677.53B KRW.

Is 456160 a Buy or Sell From a Technical Analyst Perspective?

Based on today's G2GBio moving averages and other technical indicators, the daily buy/sell signal for 456160 stock is Buy.

How Many Times Has G2GBio Stock Split?

G2GBio has split 1 times. (See the 456160 stock split history page for full effective split date and price information.)

What is the current trading status of G2GBio (KOSDAQ: 456160)?

As of 20/08/2026, G2GBio (456160) is trading at a share price of 40,950 KRW, with a previous close of 40,950 KRW. The stock has fluctuated within a day range of 40,750 KRW to 43,950 KRW, while its 52-week range spans from 22,400 KRW to 200,500 KRW.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.